The strongest evidence that salicylic acid can help against cancer comes from aspirin, and it points to one cancer in particular: colon cancer. The catch is that the benefit is slow, showing up only after many years of daily use, and aspirin carries its own risk of serious bleeding. So the honest answer is a qualified yes for prevention in some people, with a doctor’s guidance, and a “not yet proven” for treatment.
How Aspirin and Salicylic Acid Are Connected
Aspirin’s chemical name is acetylsalicylic acid, and the body quickly converts it into salicylic acid, the active part. Low-dose aspirin, the kind many people take for the heart, is usually 75 to 100 mg a day. A regular tablet is about 325 mg. Plants make salicylic acid too, where it works as a hormone that switches on defenses against disease and stress.1PubMed. Systemic Acquired Resistance and Salicylic Acid: Past, Present, and Future So salicylic acid reaches people through medicine, food, and skin products, but in very different amounts. Acne washes and wart treatments put salicylic acid on the skin, not into the bloodstream in useful amounts, and no cancer-prevention evidence involves them.
Willow bark has a similar story. It was used for pain for centuries because it contains salicin, a natural relative of salicylic acid, and aspirin was developed as a gentler-to-take version of it. Natural does not mean safer here: willow bark carries similar bleeding concerns.
After you swallow an aspirin tablet, it is absorbed from the stomach and small intestine. Enzymes in the blood and liver quickly strip off part of the molecule, leaving salicylic acid circulating in the body. Aspirin itself does something salicylic acid alone does poorly: it permanently disables platelets’ ability to clump, which is why its effect on clotting outlasts the drug in your blood. When headlines mention “salicylic acid and cancer,” they usually mean aspirin, and the evidence should be read that way.
Aspirin and Colon Cancer Prevention
In long-running trials, people taking aspirin daily at 75 to 500 mg had about 24% fewer colon cancers and 35% fewer colon cancer deaths over 20 years.2PubMed Central. Aspirin for the prevention of colorectal cancer Studies tracking people in everyday life found a similar drop of about 29% in colorectal cancer among aspirin users.3PubMed Central. Aspirin and colorectal cancer: the promise of precision chemoprevention
Many of these trials were originally designed to test whether aspirin prevented heart attacks and strokes. Researchers later checked who developed cancer, using medical and cancer registry records, which gave decades of follow-up.4PubMed Central. Aspirin and colorectal cancer: the promise of precision chemoprevention Because people were randomly assigned to aspirin or not, the groups started out alike, which makes trial results more trustworthy than comparisons of people who chose aspirin themselves. The tracking studies add a second line of evidence, though aspirin users may differ in other ways, such as diet or doctor visits.
In absolute terms, the gain is smaller. Five years of daily aspirin lowered the 20-year chance of dying of colorectal cancer by about 1.8 percentage points.5PubMed. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials That works out to roughly 1 in 57 people taking it for 5 years avoiding a fatal colorectal cancer. Most people taking aspirin for 5 years would never have developed a fatal colorectal cancer either way, so the choice rests on weighing a small average gain against the bleeding risks described later. A percentage cut also applies to your starting risk: for most people the lifetime chance of colon cancer is around 4%, while people with a strong family history start higher and stand to gain more.
Where in the bowel matters too. The colon is a long tube, and cancers in its first part, on the right side, differ in some ways from those in the lower bowel and rectum. The protection was strongest in that first part, where 5 or more years of aspirin cut risk by about 70%.6PubMed. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials Protection for the lower bowel and rectum also showed up only with 5 or more years of use,7PubMed. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials so shorter use can’t be counted on for any part of the bowel.
Aspirin is also not a substitute for screening. Screening can find growths before they turn into cancer, and colonoscopy can remove them, while aspirin only lowers risk and cannot catch a cancer already forming. Keep up screening whether or not you take aspirin.
How Much and How Long It Takes
In trials, fewer colorectal cancers appeared only after about 10 years; in the first 9 years there was no clear difference.8PubMed. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies The effect depended on how long people were scheduled to take aspirin and whether they actually kept taking it.9PubMed. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies In a large study of women, risk did not drop meaningfully until more than 10 years of regular use.10PubMed Central. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer Stopping after a year or two is unlikely to bring much benefit. Bleeding risk starts with the first doses and doesn’t wait 10 years, so the decision depends on age and expected years ahead.
The delay makes sense. Colon cancers usually grow from small polyps over a decade or more, and aspirin seems to act early, on growths that would only become cancer years later.
“Regular use” means daily or most days. Occasional pain-relief doses did not show the same effect, and missed doses over years weakened the benefit in trials.
On dose, pooled trials found that doses above 75 mg a day added no extra protection.11PubMed. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials Another analysis found consistent results only at 300 mg or more a day.12PubMed. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies And women who took more than 14 standard tablets a week for over 10 years had about half the risk.13PubMed Central. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer The right dose is still debated, and higher doses raise bleeding risk.
Other Cancers Linked to Aspirin
Low-dose aspirin taken for at least a year has been linked to about 41% fewer esophageal cancers and 54% fewer stomach cancers.14PubMed Central. The role of aspirin in preventing gastrointestinal cancers In people with chronic liver disease, regular aspirin users had roughly half the rate of liver cancer,15PubMed. Regular Aspirin Use Is Associated with a Reduced Risk of Hepatocellular Carcinoma (HCC) in Chronic Liver Disease: a Systematic Review and Meta-analysis and in that group aspirin did not raise the risk of major digestive bleeding.16PubMed. Regular Aspirin Use Is Associated with a Reduced Risk of Hepatocellular Carcinoma (HCC) in Chronic Liver Disease: a Systematic Review and Meta-analysis
These figures come from tracking aspirin users, not from trials. Aspirin users may have more doctor visits, take other medicines, or have different health conditions, any of which could explain part of the gap. A large percentage drop in a rare cancer can also be a small number of people in absolute terms.
Esophageal and stomach cancers are both linked to long-standing irritation or inflammation in the lining of the digestive tract, and aspirin’s anti-inflammatory action is one possible explanation. These findings involved shorter use than the colon results. No guideline currently recommends aspirin to prevent these cancers.
People with hepatitis or cirrhosis can have clotting problems, so bleeding risk varies. The liver finding is promising but not yet standard advice, so ask your liver specialist before starting aspirin.
Can It Help After a Cancer Diagnosis
In Danish women treated for breast cancer, low-dose aspirin users had about 20% lower chance of recurrence within 5 years.17PubMed Central. Association between low-dose aspirin use and breast cancer recurrence: a Danish nationwide cohort study with up to 23 years of follow-up After prostate removal, 85% of aspirin users had no sign of returning cancer at 3 years, versus about 75% of non-users.18PubMed Central. Impact of aspirin on biochemical recurrence of prostate cancer after robot assisted radical prostatectomy in a multicenter retrospective cohort study Both were studies of past records, which can show a link but not prove cause.
Aspirin users may differ from non-users in other ways, and only a trial that randomly assigns aspirin or a placebo can separate aspirin’s effect from those differences. Several such trials are underway or have reported, so the answer may change. Until then, the recurrence findings are leads for researchers, not reasons to start aspirin alone.
Tumor genetics may matter. Among colon cancer patients whose tumors carried a PIK3CA mutation (a change in a gene that helps control cell growth), regular aspirin after diagnosis was linked to longer survival.19PubMed Central. Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival Patients without that mutation did not seem to benefit.20PubMed Central. Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival A later trial in such patients found no clear benefit, though pooling trials suggested fewer recurrences.21PubMed Central. Adjuvant aspirin for colorectal cancer with PIK3CA-mutated and COX-2 overexpressed tumours: the ASCOLT translational research study and meta-analysis Your oncologist may know your tumor’s genetic results, which can shape this conversation.
In the lab, aspirin blocked platelets from clumping around cancer cells in the blood, which reduced spread to the lungs in animals.22PubMed Central. Aspirin blocks formation of metastatic intravascular niches by inhibiting platelet-derived COX-1/thromboxane A2 That may work because platelets can cloak cancer cells and hide them from immune cells that would kill them.23PubMed Central. Platelets and Metastasis: New Implications of an Old Interplay Salicylic acid also killed leukemia cells in dishes, but only at concentrations far above what aspirin doses reach in the blood.24PubMed. Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells Many lab successes fail in human trials, so these results don’t show aspirin works as a treatment. New aspirin-based drugs are being designed, but they are not available outside research.
Talk to your cancer team before taking aspirin. It can raise bleeding during surgery and with some chemotherapy drugs that lower platelets. Bring up any daily aspirin you already take, ask whether your tumor was tested for a PIK3CA change, and never replace prescribed treatment with aspirin.
The Bleeding Risk
Aspirin raises the risk of digestive bleeding and of strokes caused by bleeding in the brain.25U.S. Preventive Services Task Force. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication In a study of over 600,000 people, about 4.6% of long-term low-dose aspirin users had digestive bleeding versus 2.7% of non-users.26PubMed. Risk of gastrointestinal bleeding and benefit from colorectal cancer reduction from long-term use of low-dose aspirin: A retrospective study of 612 509 patients Deaths from bleeding rose only slightly, about 0.40% versus 0.36%.27PubMed. Risk of gastrointestinal bleeding and benefit from colorectal cancer reduction from long-term use of low-dose aspirin: A retrospective study of 612 509 patients The harms are small for adults 59 or younger and small to moderate for those 60 to 69.28U.S. Preventive Services Task Force. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication
The gap is about 1.9 percentage points, so roughly 2 more people in 100 had digestive bleeding over the study period. Most bleeds are not fatal, but a bleed can mean hospital care, transfusion, or procedures. Some things raise your own risk: past stomach ulcers or bleeding, blood thinners, steroids, regular ibuprofen or naproxen, heavy drinking, and older age.
Know the warning signs. Black, tarry stools or vomit that looks like coffee grounds, unusual bruising, or nosebleeds that won’t stop all call for medical attention. A sudden severe headache, weakness, or trouble speaking needs emergency care.
What Guidelines Say Now
In 2016, US guidelines advised low-dose aspirin for some adults aged 50 to 59 partly to prevent colorectal cancer.29Cancer Therapy Advisor. USPSTF No Longer Recommends Aspirin as Prophylaxis for Colorectal Cancer The current guideline says there is not enough evidence to recommend aspirin for that purpose and dropped colorectal cancer from the advice.30Cancer Therapy Advisor. USPSTF No Longer Recommends Aspirin as Prophylaxis for Colorectal Cancer Reviewers looked at newer studies, including follow-up data on cancer.31uspreventiveservicestaskforce.org. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication Aspirin for cancer prevention is now a case-by-case decision rather than routine advice.
The 2016 recommendation relied on estimates that projected cancer benefit over many years. Newer trials in older, healthy adults found that bleeding harms were larger than expected and the benefit smaller. Some people may still want to discuss it with a doctor: those with inherited syndromes like Lynch syndrome, where specialists sometimes consider aspirin; people already taking aspirin for heart reasons; and people with low bleeding risk and many years ahead.
If you already take daily aspirin, don’t stop suddenly without advice, especially after a heart attack or stent. Ask whether your reasons still apply, and review it again as you get older and bleeding risk rises.
Salicylic Acid From Fruit and Vegetables
Salicylic acid shows up in the blood of people who take no aspirin, coming from fruits and vegetables.32PubMed Central. Salicylic acid in the serum of subjects not taking aspirin. Comparison of salicylic acid concentrations in the serum of vegetarians, non-vegetarians, and patients taking low dose aspirin Vegetarians have higher levels than meat eaters,33PubMed Central. Salicylic acid in the serum of subjects not taking aspirin. Comparison of salicylic acid concentrations in the serum of vegetarians, non-vegetarians, and patients taking low dose aspirin and people who ate more than about 5 servings of produce the day before had higher levels.34PubMed. Circulating salicylic acid is related to fruit and vegetable consumption in healthy subjects
Levels vary a lot between foods, and herbs and spices like curry powder and thyme are among the richer sources. Cooking and processing can change how much remains, so counting intake from a plate is imprecise.
Still, these blood levels are many times lower than what low-dose aspirin produces. The effects aspirin has on platelets are not expected from food. Salicylic acid may be one small part of why produce-rich diets are healthy, but it is not a stand-in for aspirin.
Eating plenty of fruits, vegetables, herbs, and spices is good for overall cancer risk anyway. Fiber-rich diets and less red and processed meat are tied to lower colon cancer risk. There is no need for salicylate supplements.

